82VS
Boston, Massachusetts82vs.com
Overview
82VS is a venture studio and the investment arm of Alloy Therapeutics that builds and invests in capital-efficient, asset-focused pharmaceutical and biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Epana Bio | Mar 2025 | Seed | Co-investor |
| Ypsilon Therapeutics | Nov 2024 | Seed | Co-investor |
| Arpelos Biosciences | Mar 2024 | Seed | Co-investor |
| Cantai Therapeutics | Nov 2023 | Seed | Lead |
| Aldebaran Therapeutics | Feb 2022 | Accelerator | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
